Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001192482-20-000816

Chief Scientific Officer bought 3,599 shares at $2.28 ($8,199)

From the SEC's structured data for this filing

Trades in this filing

NEIL GARRY ARTHUR · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-12-10 Purchase : show line 1 in the form +3,599 $2.28 $8,199 77,680 D
Open-market purchases · 3,599 sh · avg $2.28 · $8,199
Loading xslF345X03/edgar.xml…